CompletedNCT00074776
Lithium or lamotrigine for depression in bipolarity type II
Medication studyAges 18–55United States
Understand this study
Who was this study for?
This study was for people with bipolarity. Listed age limits: 18 years to 55 years. Other eligibility criteria applied.
- Listed locations
- DallasSee all locations and recruitment
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Study information
Study start dateMay 2003
- Recruitment status
- Completed
- Enrollment listed in the registry
- 102
- Sponsor
- Stanford University
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- United States
- Age range
- From 18 Years to 55 Years
- Official registry ID
- NCT00074776
- Official title
Show the full official title
Acute Treatment of Bipolar II Depression
Get this study by email
Recruitment & locations
CompletedDallas
Questions about this study
Who is behind this study?
The study sponsor is Stanford University, a university.
Did this study involve medication?
Yes. The study involved medication, including lithium and lamotrigine.
Who was this study for?
This study was for people with bipolarity. Listed age limits: 18 years to 55 years. Other eligibility criteria applied.
